CT-322

Known as: CT322, VEGFR-2 inhibitor CT-322

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2009

2009

Abstract #LB-286: Combination of the anti-angiogenic AdnectinTM BMS-844203 (CT-322) and Temozolomide provides a survival advantage in an intracanial glioblastoma model

Carlos E. SanchezAyguen Sahin B. Carter
2009
Corpus ID: 53900157

AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO INTRODUCTION: Despite surgery, radiation, and chemotherapy, the 14.6 month…